Social Return on Investment of Social Prescribing via a Diabetes Technician for Preventing Type 2 Diabetes Progression
International Journal of Environmental Research and Public Health · 07.06.2023 · 20 (12) · 6074
DOI: 10.3390/ijerph20126074 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 07.06.2023. Verfasst von Adam Skinner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor LL57 2PZ, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bangor University and Conwy West Primary Care Cluster.
Themen: Diabetes mellitus
Abstract (Originalsprache)
In Wales, the prevalence of Type 2 Diabetes Mellitus (T2DM) has increased from 7.3% in 2016 to 8% in 2020, creating a major concern for the National Health Service (NHS). Social prescribing (SP) has been found to decrease T2DM prevalence and improve wellbeing. The MY LIFE programme, a scheme evaluated between June 2021 and February 2022 in the Conwy West Primary Care Cluster, aimed to prevent T2DM by referring prediabetic patients with a BMI of ≥30 to a diabetes technician (DT), who then signposted patients to community-based SP programmes, such as the National Exercise Referral Scheme (NERS), KindEating, and Slimming World. Although some patients engaged with SP, others chose to connect only with the DT. A Social Return on Investment (SROI) analysis was conducted to evaluate those patients who engaged with the DT plus SP, and those who connected solely with the DT. Relevant participant outcomes included ‘mental wellbeing’ and ‘good overall health’, which were measured at baseline (n = 54) and at the eight-week follow-up (n = 24). The estimated social value for every GBP 1 invested for participants who engaged with the ‘DT only’ ranged from GBP 4.67 to 4.70. The social value for participants who engaged with the ‘DT plus SP programme’ ranged from GBP 4.23 to 5.07. The results indicated that most of the social value generated was associated with connecting with the DT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor LL57 2PZ, UK.
- Faculty of Nursing and Midwifery, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
ORCID-Profile: Adam Skinner, Ned Hartfiel, Mary Lynch, Rhiannon Tudor Edwards
Förderung
- Bangor University and Conwy West Primary Care Cluster
Zitieren
APA
Skinner, A., Hartfiel, N., Lynch, M., Jones, A. W., & Edwards, R. T. (2023). Social Return on Investment of Social Prescribing via a Diabetes Technician for Preventing Type 2 Diabetes Progression. International Journal of Environmental Research and Public Health, 20(12), 6074. https://doi.org/10.3390/ijerph20126074
Vancouver
Skinner A, Hartfiel N, Lynch M, Jones AW, Edwards RT. Social Return on Investment of Social Prescribing via a Diabetes Technician for Preventing Type 2 Diabetes Progression. International Journal of Environmental Research and Public Health. 2023;20(12):6074. doi:10.3390/ijerph20126074
BibTeX
@article{Skinner2023,
author = {Skinner, Adam and Hartfiel, Ned and Lynch, Mary and Jones, Aled Wyn and Edwards, Rhiannon Tudor},
title = {Social Return on Investment of Social Prescribing via a Diabetes Technician for Preventing Type 2 Diabetes Progression},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
volume = {20},
number = {12},
pages = {6074},
doi = {10.3390/ijerph20126074}
}
EUVIMED